JESSICA LIPP: Open Payments
NPI 1144713934 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 12 payments from 10 companies in 2025. Trend: 2023 $226 · 2024 $250 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $82 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Exeltis, USA Inc. | 1 | $17 |
| MILLICENT US INC | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Corium, LLC | 1 | $8 |
Products named: ZURZUVAE, MYFEMBREE, NOVASURE, BEXSERO, Veozah, SLYND, FEMLYV, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
